Clinical Trials Search at Vanderbilt-Ingram Cancer Center

GS-US-356-5413 Study of Females Exposed to Eleclazine

Disease Sites:

Not Available

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Hung, Rebecca

Participating Institutions:

Vanderbilt University

Open Date:

07-10-2023

Trial Type:

Other

Protocol ID:

CRE-CHF0013

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available